--- title: Inhaled Nitric Oxide – DEFENSE HEALTH AGENCY (DHA) | Due Oct 22, 2026 - MatchAwards description: Inhaled Nitric Oxide. DEFENSE HEALTH AGENCY (DHA). Solicitation HT940827Q0002. NAICS 325412 - Pharmaceutical Preparation Manufacturing. Deadline 2026-10-22. NOTICE OF INTENT TO SOLE SOURCE: The Defense Health Agency – Healthcare Contracting Division – South, intends to award a sole source... canonical: https://matchawards.com/defense_health_agency_dha/posts/117407495746501451 og:image: https://matchawards.com/home_logo.png og:image:width: 130 og:image:height: 130 twitter:card: MatchAwards.com twitter:image: https://matchawards.com/home_logo.png og:site_name: MatchAwards og:type: article og:title: Inhaled Nitric Oxide – DEFENSE HEALTH AGENCY (DHA) | Due Oct 22, 2026 og:url: https://matchawards.com/defense_health_agency_dha/posts/117407495746501451 og:description: Inhaled Nitric Oxide. DEFENSE HEALTH AGENCY (DHA). Solicitation HT940827Q0002. NAICS 325412 - Pharmaceutical Preparation Manufacturing. Deadline 2026-10-22. NOTICE OF INTENT TO SOLE SOURCE: The Defense Health Agency – Healthcare Contracting Division – South, intends to award a sole source... og:image: https://matchawards.com/system/accounts/avatars/000/000/149/original/4a29a629b0aab3df.png?1639145829 og:image:width: 120 og:image:height: 120 twitter:card: summary --- # Inhaled Nitric Oxide Agency [DEFENSE HEALTH AGENCY (DHA)](/defense%5Fhealth%5Fagency%5Fdha) Office SAN ANTONIO, USA Notice type Sources Sought Solicitation number HT940827Q0002 NAICS [325412 - Pharmaceutical Preparation Manufacturing](/groups/360) PSC 6505 - DRUGS AND BIOLOGICALS Category [Drugs and Pharmaceutical Products (10.1)](/categories/medical/drugs-and-pharmaceutical-products) Posted 2026-10-08 Deadline 2026-10-22 Place of performance 0, Texas 78234, UNITED STATES ## Description NOTICE OF INTENT TO SOLE SOURCE: The Defense Health Agency – Healthcare Contracting Division – South, intends to award a sole source contract in accordance with RFO FAR 8.104 (Use of Existing Contracts) to INO THERAPEUTICS LLC, to procure delivery of Inhaled Nitric Oxide (iNO) for use at the Department of Medicine. at Brooke Army Medical Center, Fort Sam Houston, Texas. The period of performance is 01 JAN 2027 – 31 DEC 2027, plus four (4) option years. This notice serves to announce the Government’s intent to sole source this requirement and determine if any other sources exist. Interested sources with the demonstrated capability to meet all of the technical requirements outlined in this notice are invited to submit, in writing. Responses must include clear and convincing evidence that competition would be beneficial to the Government and would not be cost or schedule prohibitive. Respondents are responsible for appropriately marking any proprietary information. Responses will not be returned. The contractor shall deliver the following crucial elements: (a) the supply of nitric oxide for inhalation, the pharmaceutical drug essential for the therapy (800 parts per million \[PPM\]); (b) a specialized Delivery Device that meets the precise criteria outlined in the iNO product label for safe and effective administration, (c) all necessary maintenance and calibration items, accessories, and disposable supplies required for the ongoing operation of the system, and (d) a range of support services, including training, maintenance, pick-up and delivery logistics. This synopsis/notice of intent to sole source is issued in accordance with Federal Acquisition Regulation (FAR) Revolutionary FAR Overhaul (RFO) 5.101 and 12.102 and will be posted for 15 days. Response Due Date: October 22, 2026 by 12:00 PM (CST) Submit to: Contracting Officer: Joe D. Wells at joe.d.wells3.civ@health.mil. . ## Contacts * Dulce Bares * Joe Wells Email and phone are in the source notice. [Source notice](https://sam.gov/workspace/contract/opp/ae622bde8d6e45c0afccaf591bb497f2/view) ```json {"@context":"https://schema.org","@type":"Demand","name":"Inhaled Nitric Oxide","description":"NOTICE OF INTENT TO SOLE SOURCE: The Defense Health Agency – Healthcare Contracting Division – South, intends to award a sole source contract in accordance with RFO FAR 8.104 (Use of Existing Contracts) to INO THERAPEUTICS LLC, to procure delivery of Inhaled Nitric Oxide (iNO) for use at the Department of Medicine. at Brooke Army Medical Center, Fort Sam Houston, Texas. The period of performance is 01 JAN 2027 – 31 DEC 2027, plus four (4) option years. This notice serves to announce the Government’s intent to sole source this requirement and determine if any other sources exist. Interested sources with the demonstrated capability to meet all of the technical requirements outlined in this notice are invited to submit, in writing. Responses must include clear and convincing evidence that competition would be beneficial to the Government and would not be cost or schedule prohibitive. Respondents are responsible for appropriately marking any proprietary information. Responses will not be returned. The contractor shall deliver the following crucial elements: (a) the supply of nitric oxide for inhalation, the pharmaceutical drug essential for the therapy (800 parts per million [PPM]); (b) a specialized Delivery Device that meets the precise criteria outlined in the iNO product label for safe and effective administration, (c) all necessary maintenance and calibration items, accessories, and disposable supplies required for the ongoing operation of the system, and (d) a range of support services, including training, maintenance, pick-up and delivery logistics. This synopsis/notice of intent to sole source is issued in accordance with Federal Acquisition Regulation (FAR) Revolutionary FAR Overhaul (RFO) 5.101 and 12.102 and will be posted for 15 days. Response Due Date: October 22, 2026 by 12:00 PM (CST) Submit to: Contracting Officer: Joe D. Wells at joe.d.wells3.civ@health.mil. .","url":"https://matchawards.com/defense_health_agency_dha/posts/117407495746501451","identifier":"HT940827Q0002","category":"325412 - Pharmaceutical Preparation Manufacturing","additionalProperty":[{"@type":"PropertyValue","propertyID":"PSC","name":"PSC","value":"6505 - DRUGS AND BIOLOGICALS"},{"@type":"PropertyValue","propertyID":"CM category","name":"Category Management category","value":"10.1 Drugs and Pharmaceutical Products","url":"https://matchawards.com/categories/medical/drugs-and-pharmaceutical-products"}],"availabilityStarts":"2026-10-08","availabilityEnds":"2026-10-22","areaServed":"0, Texas 78234, UNITED STATES","sameAs":"https://sam.gov/workspace/contract/opp/ae622bde8d6e45c0afccaf591bb497f2/view"} ```